
Trump's $2.8B bomb sale to Israel draws bipartisan backlash over Gaza civilian harm
The Trump administration plans a $2.8 billion package to sell Israel 40,000 bombs (20,000 MK-84s and 20,000 BLU-117s) funded through Foreign Military Financing, a landmark sale that has drawn bipartisan criticism over civilian harm in Gaza; Congress has been notified and some lawmakers say they will try to block it, while analysts view the timing as reinforcing unconditional U.S. support for Israel.

